Natco Pharma net profit slips 35pc to Rs 104 crore in Q3
New Delhi: Drug firm Natco Pharma on Wednesday reported a 34.46 per cent drop in consolidated net profit to Rs 104.4 crore for the quarter ended December 2019.
The company had posted a net profit of Rs 159.3 crore for the corresponding period of the previous fiscal, Natco Pharma said in a filing to BSE.
Consolidated total income stood at Rs 513 crore for the quarter under consideration. It was Rs 580 crore for the same period a year ago.
"The company continues to face margin pressures in its Hepatitis C portfolio," the filing said.
The company's board has recommended a third interim dividend of Rs 3.50 per equity share of Rs 2 each.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at firstname.lastname@example.org. Check out more about our bureau/team here